Cover Image

Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by Nucleoside, Nucleotide, and Non-Nucleoside Reverse Transcriptase Inhibitors

Many drug interactions with drugs used for the therapy of human immunodeficiency virus (HIV) occur at the level of different cytochrome P450 isozymes. Increasing evidence suggests that antiretrovirals may also modify activity and expression of active drug transport systems. Such interactions may alt...

Full description

Saved in:
Bibliographic Details
Main Authors: Weiß, Johanna (Author) , Theile, Dirk (Author) , Ketabi-Kiyanvash, Nahal (Author) , Lindenmaier, Heike (Author) , Haefeli, Walter E. (Author)
Format: Article (Journal)
Language:English
Published: February 26, 2007
In: Drug metabolism and disposition
Year: 2007, Volume: 35, Issue: 3, Pages: 340-344
ISSN:1521-009X
DOI:10.1124/dmd.106.012765
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1124/dmd.106.012765
Verlag, lizenzpflichtig, Volltext: https://dmd.aspetjournals.org/content/35/3/340
Get full text
Author Notes:Johanna Weiss, Dirk Theile, Nahal Ketabi-Kiyanvash, Heike Lindenmaier, Walter Emil Haefeli

MARC

LEADER 00000caa a2200000 c 4500
001 1757703209
003 DE-627
005 20240131165507.0
007 cr uuu---uuuuu
008 210512s2007 xx |||||o 00| ||eng c
024 7 |a 10.1124/dmd.106.012765  |2 doi 
035 |a (DE-627)1757703209 
035 |a (DE-599)KXP1757703209 
035 |a (OCoLC)1341408983 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Weiß, Johanna  |e VerfasserIn  |0 (DE-588)1050230906  |0 (DE-627)783666322  |0 (DE-576)404441114  |4 aut 
245 1 0 |a Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by Nucleoside, Nucleotide, and Non-Nucleoside Reverse Transcriptase Inhibitors  |c Johanna Weiss, Dirk Theile, Nahal Ketabi-Kiyanvash, Heike Lindenmaier, Walter Emil Haefeli 
264 1 |c February 26, 2007 
300 |a 5 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 12.05.2021 
520 |a Many drug interactions with drugs used for the therapy of human immunodeficiency virus (HIV) occur at the level of different cytochrome P450 isozymes. Increasing evidence suggests that antiretrovirals may also modify activity and expression of active drug transport systems. Such interactions may alter drug absorption, elimination, and also drug distribution and reach clinical importance if thereby access to the target site is affected. Beyond P-glycoprotein, the family of multidrug resistance-related proteins (MRP/ABCC) substantially contributes to the elimination of numerous drugs and their metabolites. Because the interaction of MRPs with non-HIV protease inhibitor antiretrovirals has not been studied thoroughly, we investigated whether important non-nucleoside reverse transcriptase inhibitors (NNRTI) (delavirdine, efavirenz, and nevirapine), nucleoside reverse transcriptase inhibitors (NRTI) (abacavir, emtricitabine, and lamivudine), and tenofovir as a nonnucleotide reverse transcriptase inhibitor can interact with MRP1, MRP2, and MRP3 in vitro. Inhibition of these ABC transporters was quantified by confocal laser-scanning microscopy using the 5-chloromethylfluorescein diacetate assay. With the exception of abacavir, which had no effect on MRP3, all the test compounds increased intracellular 5-chloromethylfluorescein fluorescence in a concentration-dependent manner, and this effect was observed in all the overexpressing cell lines but not in the parental cell line, indicating inhibition of MRP1, MRP2, and MRP3. In conclusion, the present study provides the first evidence for a significant and concentration-dependent inhibition of MRPs by NNRTI, NRTI, and tenofovir, which was most pronounced for delavirdine, efavirenz, and emtricitabine, suggesting that this might contribute to some of the known drug interactions impairing HIV therapy and also to the superior effectiveness of combination pharmacotherapy. 
700 1 |a Theile, Dirk  |e VerfasserIn  |0 (DE-588)1019114428  |0 (DE-627)684195658  |0 (DE-576)356996360  |4 aut 
700 1 |a Ketabi-Kiyanvash, Nahal  |e VerfasserIn  |0 (DE-588)13575285X  |0 (DE-627)69375253X  |0 (DE-576)283424117  |4 aut 
700 1 |a Lindenmaier, Heike  |e VerfasserIn  |0 (DE-588)1317608933  |0 (DE-627)1879501058  |4 aut 
700 1 |a Haefeli, Walter E.  |d 1958-  |e VerfasserIn  |0 (DE-588)124572359  |0 (DE-627)656806141  |0 (DE-576)340514221  |4 aut 
773 0 8 |i Enthalten in  |t Drug metabolism and disposition  |d Bethesda, Md. : ASPET, 1973  |g 35(2007), 3, Seite 340-344  |h Online-Ressource  |w (DE-627)306657198  |w (DE-600)1500213-5  |w (DE-576)309203163  |x 1521-009X  |7 nnas  |a Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by Nucleoside, Nucleotide, and Non-Nucleoside Reverse Transcriptase Inhibitors 
773 1 8 |g volume:35  |g year:2007  |g number:3  |g pages:340-344  |g extent:5  |a Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by Nucleoside, Nucleotide, and Non-Nucleoside Reverse Transcriptase Inhibitors 
856 4 0 |u https://doi.org/10.1124/dmd.106.012765  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://dmd.aspetjournals.org/content/35/3/340  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210512 
993 |a Article 
994 |a 2007 
998 |g 124572359  |a Haefeli, Walter E.  |m 124572359:Haefeli, Walter E.  |d 910000  |d 910100  |e 910000PH124572359  |e 910100PH124572359  |k 0/910000/  |k 1/910000/910100/  |p 5  |y j 
998 |g 1019114428  |a Theile, Dirk  |m 1019114428:Theile, Dirk  |d 910000  |d 910100  |e 910000PT1019114428  |e 910100PT1019114428  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 1050230906  |a Weiß, Johanna  |m 1050230906:Weiß, Johanna  |d 910000  |d 910100  |e 910000PW1050230906  |e 910100PW1050230906  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1757703209  |e 3927612634 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1757703209","relHost":[{"disp":"Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by Nucleoside, Nucleotide, and Non-Nucleoside Reverse Transcriptase InhibitorsDrug metabolism and disposition","physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"part":{"year":"2007","pages":"340-344","text":"35(2007), 3, Seite 340-344","extent":"5","issue":"3","volume":"35"},"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.1973 -"],"note":["Gesehen am 23.06.2025"],"recId":"306657198","corporate":[{"roleDisplay":"Herausgebendes Organ","role":"isb","display":"American Society for Pharmacology and Experimental Therapeutics"}],"name":{"displayForm":["American Society for Pharmacology and Experimental Therapeutics"]},"origin":[{"dateIssuedDisp":"1973-","publisher":"ASPET","publisherPlace":"Bethesda, Md.","dateIssuedKey":"1973"}],"id":{"zdb":["1500213-5"],"eki":["306657198"],"issn":["1521-009X"]},"title":[{"title_sort":"Drug metabolism and disposition","title":"Drug metabolism and disposition"}]}],"note":["Gesehen am 12.05.2021"],"name":{"displayForm":["Johanna Weiss, Dirk Theile, Nahal Ketabi-Kiyanvash, Heike Lindenmaier, Walter Emil Haefeli"]},"person":[{"family":"Weiß","roleDisplay":"VerfasserIn","role":"aut","given":"Johanna","display":"Weiß, Johanna"},{"display":"Theile, Dirk","family":"Theile","roleDisplay":"VerfasserIn","role":"aut","given":"Dirk"},{"display":"Ketabi-Kiyanvash, Nahal","given":"Nahal","role":"aut","roleDisplay":"VerfasserIn","family":"Ketabi-Kiyanvash"},{"display":"Lindenmaier, Heike","role":"aut","roleDisplay":"VerfasserIn","given":"Heike","family":"Lindenmaier"},{"given":"Walter E.","roleDisplay":"VerfasserIn","role":"aut","family":"Haefeli","display":"Haefeli, Walter E."}],"origin":[{"dateIssuedDisp":"February 26, 2007","dateIssuedKey":"2007"}],"id":{"doi":["10.1124/dmd.106.012765"],"eki":["1757703209"]},"title":[{"title_sort":"Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by Nucleoside, Nucleotide, and Non-Nucleoside Reverse Transcriptase Inhibitors","title":"Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by Nucleoside, Nucleotide, and Non-Nucleoside Reverse Transcriptase Inhibitors"}],"physDesc":[{"extent":"5 S."}],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"}} 
SRT |a WEISSJOHANINHIBITION2620 

Similar Items